Reference priceKRW ₩850,500.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Kisqali |
|---|---|
| Manufacturer | NOVARTIS |
| Prescription required | Yes |
Kisqali 600mg daily Tablets 3 x 21 blst(Ribociclib)
ribociclib
Description
Kisqali 600mg daily Tablets 3 x 21 blst(Ribociclib) is a medicine catalog record in the MediPriceHub database. Active ingredient: ribociclib. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: NOVARTIS. Therapeutic category: Medicine Library > Oncology Medicines > Breast Cancer Drugs. Pack information: 600 / 63. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
KISQALI is a kinase inhibitor indicated: in combination with an aromatase inhibitor for the adjuvant treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative stage II and III early breast cancer at high risk of recurrence. for the treatment of adults with HR-positive, HER2-negative advanced or metastatic breast cancer in combination with: an aromatase inhibitor as initial endocrine-based therapy; or fulvestrant as initial endocrine-based therapy or following disease progression on endocrine therapy. an aromatase inhibitor as initial endocrine-based therapy; or fulvestrant as initial endocrine-based therapy or following disease progression on endocrine therapy.How to Use
Use ribociclib under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: ribociclib. Pack size: 600 / 63. Pack unit: box. Manufacturer: NOVARTIS. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Breast Cancer Drugs. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.이 정보는 참고용입니다. 의약품 사용 전 의료 전문가와 상담하세요.